NASDAQ:NSPH - Nanosphere Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.69 +1.69 (+∞) (As of 07/1/2016)Previous Close$1.69Today's Range$1.69 - $1.6952-Week Range$0.48 - $3.64VolumeN/AAverage Volume886,293 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market. Receive NSPH News and Ratings via Email Sign-up to receive the latest news and ratings for NSPH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:NSPH Previous Symbol CUSIPN/A CIK1105184 Webwww.nanosphere.us Phone+1-847-4009000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Nanosphere (NASDAQ:NSPH) Frequently Asked Questions What is Nanosphere's stock symbol? Nanosphere trades on the NASDAQ under the ticker symbol "NSPH." How were Nanosphere's earnings last quarter? Nanosphere, Inc. (NASDAQ:NSPH) issued its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.55) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.59) by $0.04. The medical research company earned $6.60 million during the quarter, compared to the consensus estimate of $6.50 million. The company's revenue for the quarter was up 43.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($1.29) EPS. View Nanosphere's Earnings History. Has Nanosphere been receiving favorable news coverage? News coverage about NSPH stock has been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nanosphere earned a coverage optimism score of 1.2 on InfoTrie's scale. They also assigned news articles about the medical research company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. What other stocks do shareholders of Nanosphere own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nanosphere investors own include Cerus (CERS), AEterna Zentaris (AEZS), Molecular Templates (MTEM), Sarepta Therapeutics (SRPT), XOMA (xoma), BIOLASE (BIOL), EXACT Sciences (EXAS), Novavax (NVAX), Actinium Pharmaceuticals (ATNM) and Northwest Biotherapeutics (NWBO). How do I buy shares of Nanosphere? Shares of NSPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Nanosphere's stock price today? One share of NSPH stock can currently be purchased for approximately $1.69. What is Nanosphere's official website? The official website for Nanosphere is http://www.nanosphere.us/. How can I contact Nanosphere? Nanosphere's mailing address is 4088 Commercial Ave, NORTHBROOK, IL 60062-1829, United States. The medical research company can be reached via phone at +1-847-4009000. MarketBeat Community Rating for Nanosphere (NASDAQ NSPH)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 137 (Vote Outperform)Underperform Votes: 133 (Vote Underperform)Total Votes: 270MarketBeat's community ratings are surveys of what our community members think about Nanosphere and other stocks. Vote "Outperform" if you believe NSPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/22/2019 by MarketBeat.com StaffFeatured Article: What is a support level?